These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

717 related items for PubMed ID: 1963808

  • 1. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
    Tricklebank MD, Honoré T, Iversen SD, Kemp JA, Knight AR, Marshall GR, Rupniak NM, Singh L, Tye S, Watjen F.
    Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
    [Abstract] [Full Text] [Related]

  • 2. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W, Hönack D.
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [Abstract] [Full Text] [Related]

  • 3. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P, Ducić I, Puia G, Arban R, Walser A, Guidotti A, Costa E.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2.
    Knoflach F, Benke D, Wang Y, Scheurer L, Lüddens H, Hamilton BJ, Carter DB, Mohler H, Benson JA.
    Mol Pharmacol; 1996 Nov; 50(5):1253-61. PubMed ID: 8913357
    [Abstract] [Full Text] [Related]

  • 5. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
    Jenck F, Moreau JL, Bonetti EP, Martin JR, Haefely WE.
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1121-7. PubMed ID: 1356150
    [Abstract] [Full Text] [Related]

  • 6. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
    Langen B, Egerland U, Bernöster K, Dost R, Unverferth K, Rundfeldt C.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
    [Abstract] [Full Text] [Related]

  • 7. The affinities, potencies and efficacies of some benzodiazepine-receptor agonists, antagonists and inverse-agonists at rat hippocampal GABAA-receptors.
    Kemp JA, Marshall GR, Wong EH, Woodruff GN.
    Br J Pharmacol; 1987 Jul; 91(3):601-8. PubMed ID: 3038246
    [Abstract] [Full Text] [Related]

  • 8. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
    Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H, Sanger DJ.
    Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Labelling of diazepam-sensitive and -insensitive benzodiazepine receptors with [3H]tert-butyl-8-chloro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo [1,5-a][1,4]benzodiazepine 3-carboxylate (ZG-63).
    Wong G, Gu ZQ, de Costa B, Skolnick P.
    Eur J Pharmacol; 1993 Sep 15; 247(1):57-63. PubMed ID: 8258361
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.
    Bernard PS, Bennett DA, Pastor G, Yokoyama N, Liebman JM.
    J Pharmacol Exp Ther; 1985 Oct 15; 235(1):98-105. PubMed ID: 2995650
    [Abstract] [Full Text] [Related]

  • 15. Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
    Serra M, Ghiani CA, Motzo C, Cuccheddu T, Floris S, Giusti P, Biggio G.
    J Pharmacol Exp Ther; 1994 Apr 15; 269(1):32-8. PubMed ID: 8169838
    [Abstract] [Full Text] [Related]

  • 16. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E, Tatarczyńska E, Chojnacka-Wójcik E.
    Neuropharmacology; 2000 Jul 24; 39(10):1858-64. PubMed ID: 10884566
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
    Carter RB, Wood PL, Wieland S, Hawkinson JE, Belelli D, Lambert JJ, White HS, Wolf HH, Mirsadeghi S, Tahir SH, Bolger MB, Lan NC, Gee KW.
    J Pharmacol Exp Ther; 1997 Mar 24; 280(3):1284-95. PubMed ID: 9067315
    [Abstract] [Full Text] [Related]

  • 19. Stereospecific transduction of behavioral effects via diazepam-insensitive GABAA receptors.
    Acri JB, Wong G, Witkin JM.
    Eur J Pharmacol; 1995 May 24; 278(3):213-23. PubMed ID: 7589157
    [Abstract] [Full Text] [Related]

  • 20. Do subtype-selective gamma-aminobutyric acid A receptor modulators have a reduced propensity to induce physical dependence in mice?
    Mirza NR, Nielsen EØ.
    J Pharmacol Exp Ther; 2006 Mar 24; 316(3):1378-85. PubMed ID: 16352707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.